SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Trading Update

17 Sep 2020 07:00

RNS Number : 2245Z
Breedon Group PLC
17 September 2020
 

 

 

 

 

NEWS RELEASE

17 September 2020

 

 

 

BREEDON GROUP PLC ("Breedon" or "the Group")

Trading Update

 

Trading performance

 

Breedon has continued to deliver an encouraging trading performance since demand began to return in early May after the COVID-19 lockdown, with the improving trend that we reported for June and July at the time of our interim results continuing into August. The Group delivered revenues for the first eight months of the year of £531 million (2019: £624 million), including a one-month contribution from our recently-acquired CEMEX assets in the UK.

 

Outlook

 

The Board has reviewed the latest management forecasts and is now in a position to reinstate guidance for the 2020 financial year. Accordingly, we currently anticipate delivering second-half underlying EBIT broadly in line with the second half of 2019, which would deliver a result in excess of the average of current full-year market expectations.*

 

We continue to be reassured by the Government's restated commitment to investment in the UK's infrastructure and by encouraging demand from the UK housing market, complemented by similar trends in the Republic of Ireland. As a provider of an essential service, we have proved our ability to deliver a resilient performance despite unprecedented disruption, which gives us considerable confidence in the long-term outlook for our business.

 

We plan to issue our customary trading update for the first 10 months of the year on 18 November 2020 and to announce our preliminary results for the year ended 31 December 2020 on 10 March 2021.

 

* The Group believes that the average of current full-year market expectations for underlying EBIT is £57 million, with a range of £49 million to £70 million.

 

- ends -

 

The information contained within this announcement is deemed by the Group to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014.

 

Note to editors

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations. Following the acquisition of a portfolio of CEMEX's UK assets (subject to implementation of the remedies required by the CMA), the Group employs over 3,500 people and has around 1 billion tonnes of mineral reserves and resources. The Group's strategy is to continue growing through organic improvement and the acquisition of businesses in the heavyside construction materials market.

For further information:

 

Breedon Group plc

Pat Ward, Group Chief Executive

Rob Wood, Group Finance Director 01332 694010

 

Stephen Jacobs, Group Head of Communications 07831 764592

 

Cenkos Securities (NOMAD and Joint Broker)

Max Hartley/Harry Hargreaves 020 7397 8900

 

Numis (Joint Broker)

Ben Stoop/Heraclis Economides 020 7260 1000

 

Teneo

Matt Denham/ Rachel Miller 020 7420 3180

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNVVRRKUKAAR
Date   Source Headline
7th Jul 20217:00 amRNSBlock listing Update
1st Jul 20216:16 pmRNSTotal Voting Rights
1st Jun 20213:49 pmRNSStandard form for notification of major holdings
1st Jun 20217:00 amRNSAcquisition
28th May 202110:02 amRNSTotal Voting Rights
7th May 20219:28 amRNSStandard form for notification of major holdings
23rd Apr 20211:46 pmRNSDirectors’ and PDMRs’ Dealings
23rd Apr 20211:37 pmRNSPDMR Dealings
20th Apr 20212:36 pmRNSResult of AGM
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 202111:04 amRNSGrant of SAYE Options and PDMR Dealings
1st Apr 20217:00 amRNSBoard Update
23rd Mar 202111:13 amRNSDirector Dealings
23rd Mar 202111:09 amRNS2020 Annual Report and Notice of AGM
10th Mar 20217:01 amRNSDirectorate Change
10th Mar 20217:00 amRNSAnnual Results 2020
26th Feb 20219:15 amRNSTotal Voting Rights
22nd Jan 20211:55 pmRNSDirector/PDMR Shareholding
22nd Jan 20218:46 amRNSAdditional Block Listing of Ordinary Shares
13th Jan 20217:00 amRNSAppointment of Corporate Broker
7th Jan 20212:45 pmRNSBlock listing Interim Review
23rd Dec 20207:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSTrading Update
3rd Dec 20207:00 amRNSUpdate on CMA's Review of Completed Acquisition
2nd Dec 20203:55 pmRNSHolding(s) in Company
1st Dec 20204:50 pmRNSHolding(s) in Company
1st Dec 20207:10 amRNSUpdate on CMA's Review of Completed Acquisition
30th Nov 20201:31 pmRNSTotal Voting Rights
24th Nov 20204:55 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSDirectorate Change
18th Nov 20207:00 amRNSTrading Update
9th Nov 20207:00 amRNSAcquisition update
30th Oct 20207:00 amRNSTotal Voting Rights
6th Oct 20207:00 amRNSDirectorate Change
30th Sep 20207:00 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSTrading Update
10th Sep 20207:13 amRNSCMA's Review of Completed Acquisition
7th Sep 202012:50 pmRNSGrant of SAYE Options and PDMR Dealings
27th Aug 20202:53 pmRNSDirectors' and PDMRs' Dealings
26th Aug 20207:14 amRNSCMA's Review of Proposed Acquisition
19th Aug 20205:30 pmRNSHolding(s) in Company
19th Aug 20205:30 pmRNSHolding(s) in Company
13th Aug 20204:09 pmRNSDirector and PDMR Dealings
3rd Aug 20207:00 amRNSCompletion of acquisition
31st Jul 20207:00 amRNSTotal Voting Rights
29th Jul 20207:00 amRNSHalf-year Report
8th Jul 20207:00 amRNSBlock listing Interim Review
6th Jul 202010:30 amRNSHolding(s) in Company
6th Jul 202010:30 amRNSHolding(s) in Company
19th Jun 20203:41 pmRNSDirector and PDMR Dealings & Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.